Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved ...
Learn how a young woman diagnosed with stage 4 non-small cell lung cancer had many treatment options because she came to MSK first.
A multi-institution team co-led by MSK researchers has pinpointed what could be the early genetic origins of breast cancer.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
In conjunction with the Structural Biology Core Facility, CEMIL enables practitioners of Cryo-EM within MSK laboratories to design innovative experiments and collect the highest quality Cryo-EM data ...
Research at MSK Our research impact Research topics Core facilities & resources ...
Hematologic oncologist Eytan Stein (shown here with nurse practitioner Coleen Ranaghan) has led the development of several new drugs for acute myeloid leukemia. Acute myeloid leukemia (AML) is one of ...